D
Till Capital Corporation TIL.V
TSX
Recommendation
Prev Close
$1.83
Volume
--
Avg Vol (90D)
1,577
Market Cap
$4.28M
Dividend & Yield
--
52-Week Range
$1.01 - $2.20
P/E (TTM)
--
EPS (TTM)
-$0.5579
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups
6/30/2025 - SeekingAlpha
Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
6/20/2025 - Zacks Investment Research
Instil Bio (TIL, $27.85) entered Downtrend as Momentum indicator drops below 0 level on Jun 17, 2025
6/18/2025 - Tickeron - Stocks
Instil Bio (TIL, $27.85) Moving Average Convergence Divergence (MACD) Histogram turned negative on June 17, 2025
6/18/2025 - Tickeron - Stocks
Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
6/16/2025 - Zacks Investment Research
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF ...
6/11/2025 - GuruFocus
Instil Bio (TIL) Enhances Axion Bio Board with New Appointment TIL Stock News
6/11/2025 - GuruFocus
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF ...
6/11/2025 - GuruFocus
Instil Bio adds Maraganore to the Board of Directors of Axion Bio
6/11/2025 - The Fly
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
6/11/2025 - Globe Newswire
Instil Bio (TIL) Receives Reiterated Buy Rating from HC Wainwright & Co. TIL Stock News
6/5/2025 - GuruFocus
Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice
6/4/2025 - Zacks Investment Research
Instil Bio (TIL) Rating Reiterated as Market Perform by JMP Securities TIL Stock News
6/2/2025 - GuruFocus
Summit Therapeutics Stock Nosedives on Mixed NSCLC Study Results
6/2/2025 - Zacks Investment Research
Instil Bio (TIL) Appoints Jamie Freedman as Chief Medical Officer
6/2/2025 - GuruFocus
Instil Bio (TIL) Appoints Jamie Freedman as Chief Medical Officer TIL Stock News
6/2/2025 - GuruFocus
Instil Bio appoints Jamie Freedman as Chief Medical Officer
6/2/2025 - SeekingAlpha.com: All News
Instil Bio appoints Jamie Freedman as Chief Medical Officer
6/2/2025 - Seeking Alpha - Healthcare
Instil Bio appoints Jamie Freedman as CMO
6/2/2025 - The Fly
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
6/2/2025 - GuruFocus
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
6/2/2025 - Globe Newswire
Video: Friday Sector Laggards: Semiconductors, Biotechnology Stocks
5/30/2025 - Market News Video
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
5/30/2025 - GuruFocus
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference TIL Stock News
5/30/2025 - GuruFocus
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
5/30/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
-$508.90K
EBITDA (TTM)
-$1.90M
EBIT (TTM)
-$1.90M
Net Income (TTM)
-$1.78M
Balance Sheet
Total Assets (Q)
$9.65M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$147.10K
Book Value Per Share (Q)
$2.61
Cash Flow
Cash from Operations (TTM)
-$1.08M
Cash from Investing (TTM)
-$152.10K
Cash from Financing (TTM)
-$4.79M
Net Change in Cash (TTM)
-$6.10M
Filings
Filing Date
Tuesday, May 27, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 18 and 22 (est)
Price History
Loading...
Beta
-0.06
7-Day Total Return
-0.55%
30-Day Total Return
0.55%
60-Day Total Return
78.43%
90-Day Total Return
78.43%
Year to Date Total Return
71.70%
1-Year Total Return
-1.62%
2-Year Total Return
-85.56%
3-Year Total Return
-99.10%
5-Year Total Return
-15.94%
52-week Low
Nov 12, 2024 - $1.01
52-week High
May 20, 2025 - $2.20
Valuation
Market Cap
$4.28M - Nano Cap
Enterprise Value
$155.70K
Price/Sales (TTM)
-11.48
Price/Book (Q)
0.70
Dividends and Shares
Shares Outstanding
3.19M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tillcap.com
Phone Number
208 635 5415
Address
Park Place
Suite 1700 - 666 Burrard Street
Vancouver, BC V6C 2X8
Country
Canada
Year Founded
2012
Business Description
Sector
Materials
Industry
Materials
Till Capital Corporation, together with its subsidiaries, operates as a mineral exploration company in Canada and the United States. The company explores for silver, gold, and other deposits. It... more